Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
May 1, 2025
 · 
Reactions
A MyLeukemiaTeam Member

I've read on the NIH.GOV website ivermectin is showing promising results. Hopefully trial studies will be coming soon, I want to try it. TKI's just aren't working for my CML or agreeing with me.

May 1, 2025
MyLeukemiaTeam

Based on current medical evidence, ivermectin is not a recognized or approved treatment for Chronic Neutrophilic Leukemia (CNL). The standard treatments that have shown effectiveness for CNL include hydroxyurea (Hydrea), immunotherapy with interferon alfa-2b, and in some cases, targeted therapy with ruxolitinib. It's Show Full Answer

Based on current medical evidence, ivermectin is not a recognized or approved treatment for Chronic Neutrophilic Leukemia (CNL). The standard treatments that have shown effectiveness for CNL include hydroxyurea (Hydrea), immunotherapy with interferon alfa-2b, and in some cases, targeted therapy with ruxolitinib. It's important to work closely with your healthcare team to develop an appropriate treatment plan. CNL is a rare condition that requires specific medical interventions. The most effective treatments have been shown to be hydroxyurea, which helps about 75% of patients experience reduced symptoms, or stem cell transplantation, which is currently the only potential cure for CNL.

May 1, 2025

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
Florida, NY

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In